Luye Pharma Group Ltd (LUP) — Financial Flexibility Index
Luye Pharma Group Ltd (LUP) has a Financial Flexibility Index of 0.02x as of June 2023. Free cash flow of €344.86 Million (operating CF €344.86 Million minus capex €0.00) represents 0% of total liabilities (€14.11 Billion). Also explore LUP shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Luye Pharma Group Ltd Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Luye Pharma Group Ltd across 10 annual periods. Check LUP strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Luye Pharma Group Ltd (2016–2025)
Year-by-year free cash flow to debt coverage for Luye Pharma Group Ltd. For the full company profile including market capitalisation, see Luye Pharma Group Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | €2.79 Billion | €1.78 Billion | €14.47 Billion | ▲ +42.2% |
| 2024 | 0.14x | €1.88 Billion | €167.76 Million | €13.86 Billion | ▼ -41.3% |
| 2023 | 0.23x | €2.76 Billion | €1.60 Billion | €11.96 Billion | ▲ +8.2% |
| 2022 | 0.21x | €2.82 Billion | €1.65 Billion | €13.21 Billion | ▲ +289.0% |
| 2021 | 0.05x | €738.57 Million | €182.37 Million | €13.47 Billion | ▼ -60.2% |
| 2020 | 0.14x | €1.73 Billion | €1.03 Billion | €12.53 Billion | ▼ -43.5% |
| 2019 | 0.24x | €2.42 Billion | €1.42 Billion | €9.94 Billion | ▲ +31.9% |
| 2018 | 0.18x | €1.77 Billion | €1.05 Billion | €9.60 Billion | ▼ -51.5% |
| 2017 | 0.38x | €1.47 Billion | €964.10 Million | €3.86 Billion | ▲ +10.5% |
| 2016 | 0.34x | €911.17 Million | €592.03 Million | €2.64 Billion | — |